US big pharma targets our PBS
The government is vowing to slash the price of medicines if it wins the election, but in the meantime, big pharma in the US has set its sights on reining in Australia’s pharmaceuticals subsidies.
Our Team
Latest
What if doctors could know your anxiety risk through your genes?
Australian researchers are trying to understand what genes could increase a person’s risk of developing an anxiety disorder and how they might respond to treatment.
Ever heard of ‘sleep divorce’? It’s more common than you think
Poor sleep can be bad for your health and put unnecessary strain on relationships and intimacy, and new data suggests Australians are less likely to seek help for it.
Scolyer: ‘I’m lucky to have more time with family’
Renowned scientist Richard Scolyer says while he has only months to live, his survival ‘gives a lot of hope’ to the efficacy of the experimental immunotherapy he trialled.
One in 5000 Aussie kids are born with the disease that killed Prince Frederik. Spotting the symptoms can be tricky
Part of the difficulty with diagnosing this genetic mutation is the nature of the disease’s symptoms, which can vary significantly from patient to patient.
Hospitalisations, E. coli, infection: The ugly reality of our cosmetic injectables industry
‘Something has to change’: Doctors ask what will it take before regulators act on our cosmetic injectables industry? | WATCH
HIV warning issued to clients of city cosmetic clinic
Health authorities in NSW have issued a warning to patients of a Sydney city cosmetic clinic, saying they may have been exposed to blood viruses.
Four tips to get the most from your health insurance
We asked insurers and consumer advocates how you can get the best value from your private health cover ahead of looming price rises. Here’s what they said.
Medical hero thanks supporters following complex brain surgery
Renowned melanoma scientist Richard Scolyer is focused on recovery after complex surgery to determine the cause of brain scan ‘changes’.
Help is on the way for regional allergy sufferers
In a win for rural healthcare, allergy sufferers in regional areas, where a lack of specialists can delay diagnosis and treatment, will receive immediate management and improved referrals.
Original URL: https://www.theaustralian.com.au/author/penny-timms/page/5